Earlier research has shown that immunotherapy-activated CD8+ T cells enhance tumor cell sensitivity to ferroptosis, and this elevated ferroptosis plays a role in reinforcing the antitumor effects of immunotherapeutic strategies [22,23]. Here, CD8A is linked to neoplasm.